Anastasios Lymperopoulos
About
In The Last Decade
Anastasios Lymperopoulos
108 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Molecular Biology 2.1k
- Cardiology and Cardiovascular Medicine 1.7k
- Cellular and Molecular Neuroscience 685
- Endocrinology, Diabetes and Metabolism 591
- Physiology 392
Countries citing papers authored by Anastasios Lymperopoulos
This map shows the geographic impact of Anastasios Lymperopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anastasios Lymperopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anastasios Lymperopoulos more than expected).
Fields of papers citing papers by Anastasios Lymperopoulos
This network shows the impact of papers produced by Anastasios Lymperopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anastasios Lymperopoulos. The network helps show where Anastasios Lymperopoulos may publish in the future.
Co-authorship network of co-authors of Anastasios Lymperopoulos
This figure shows the co-authorship network connecting the top 25 collaborators of Anastasios Lymperopoulos. A scholar is included among the top collaborators of Anastasios Lymperopoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anastasios Lymperopoulos. Anastasios Lymperopoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 10 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | Differential Roles of GRK2 and GRK5 in Cardiac Aldosterone Signaling Suggest GRK5-Mediated Cardio-protection Against Mineralocorticoids | 0 |
| 6 | 36 | |
| 7 | 39 | |
| 8 | 31 | |
| 9 | 2 | |
| 10 | 29 | |
| 11 | 110 | |
| 12 | 39 | |
| 13 | 35 | |
| 14 | 46 | |
| 15 | GRK2 and β-arrestins in cardiovascular disease: Something old, something new. | 13 |
| 16 | 67 | |
| 17 | 28 | |
| 18 | Abstract 14567: Caveolin-1 Deficiency Exacerbates Cardiac Dysfunction and Reduces Survival in Mice with Myocardial Infarction | 1 |
| 19 | 38 | |
| 20 | 7 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.